Barrington Research Reaffirms Outperform Rating for Adtalem Global Education (NYSE:CVSA)

Adtalem Global Education (NYSE:CVSA)‘s stock had its “outperform” rating restated by analysts at Barrington Research in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $170.00 price objective on the stock. Barrington Research’s price target indicates a potential upside of 33.93% from the stock’s current price.

Several other equities research analysts also recently issued reports on CVSA. Zacks Research downgraded shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Wall Street Zen lowered shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Finally, Truist Financial lifted their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $155.00.

Adtalem Global Education Trading Up 0.2%

NYSE:CVSA traded up $0.29 during trading hours on Monday, hitting $126.94. 63,404 shares of the stock traded hands, compared to its average volume of 372,361. The firm has a market capitalization of $4.32 billion, a price-to-earnings ratio of 19.77, a price-to-earnings-growth ratio of 1.05 and a beta of 0.62. The business’s 50 day simple moving average is $119.37. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36. Adtalem Global Education has a fifty-two week low of $86.97 and a fifty-two week high of $156.26.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, beating the consensus estimate of $1.73 by $0.25. The business had revenue of $487.03 million during the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The company’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. Research analysts predict that Adtalem Global Education will post 8.04 EPS for the current year.

Insider Buying and Selling at Adtalem Global Education

In other news, insider Karen Sue Cox sold 2,000 shares of the business’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $124.50, for a total transaction of $249,000.00. Following the transaction, the insider directly owned 31,596 shares in the company, valued at $3,933,702. The trade was a 5.95% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen W. Beard sold 15,874 shares of the firm’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $131.25, for a total transaction of $2,083,462.50. Following the sale, the chief executive officer owned 429,324 shares of the company’s stock, valued at approximately $56,348,775. This represents a 3.57% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have purchased 36,036 shares of company stock worth $3,635,302 and have sold 37,489 shares worth $4,815,956. Company insiders own 2.50% of the company’s stock.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.